Weight-modification trials in older adults: what should the outcome measure be?

Table 2 YOL and YHL by BMI and sex. Adjusted for age/race/smoking, and for all covariates.

	BMI	YOL (7 Yrs), adj for age, race, past smoking	YOL (7 Yrs), adj for all variables^*	YHL (7 Yrs), adj for age, race, past smoking	YHL (7 Yrs), adj for all variables^*	N
Women	<18.5	6.0	6.1	4.1	4.2	53
	18.5–19.9	6.3	6.3	4.8	4.7	90
	20.0–24.9	6.5	6.5	4.9	4.8	938
	25.0–29.9	6.6	6.5	4.8	4.8	1,044
	30+	6.5	6.6	4.4	4.7	653
Men	<18.5	5.1	5.5	3.7	4.3	14
	18.5–19.9	5.6	5.6	4.4	4.2	28
	20.0–24.9	6.0	6.0	4.5	4.4	701
	25.0–29.9	6.1	6.1	4.6	4.5	1,021
	30+	6.1	6.1	4.3	4.4	336

• The self-reported covariates were: age, gender, smoking (never or former), history of arthritis, cancer, diabetes, fair or poor self-rated health status, limitations in activities of daily living or in instrumental activities of daily living, and 10 pounds or more unintended weight loss in the year before baseline. Clinical covariates were: hypertension, cardiovascular disease (prevalent heart disease, peripheral vascular disease, or cerebrovascular disease), maximum thickness of the internal carotid artery, depression (CESD score), serum albumin, serum cholesterol, and serum creatinine.

ISSN: 1745-6215